Travel: Coronavirus

(asked on 6th July 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department has received confirmation from EU counterparts that UK citizens who are fully vaccinated against covid-19 will not find their travel to EU countries affected as a result of their having received a dose of the AstraZeneca covid-19 vaccine from batch numbers 4120Z001, 4120Z002 or 4120Z003.


Answered by
Nadhim Zahawi Portrait
Nadhim Zahawi
This question was answered on 12th July 2021

The Serum Institute of India (SII) manufactures both Vaxzevria and Covishield, branded vaccines which are the same as the University of Oxford/AstraZeneca vaccine. All SII-made doses approved by the United Kingdom regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’. The MHRA has not approved doses branded as ‘Covishield’ and none have been administered in the UK. All AstraZeneca vaccines given in the UK are the same product and appear on the NHS COVID Pass as Vaxzevria.

The European Medicines Agency has authorised the Vaxzevria vaccine and it is therefore recognised by the European Union.

Reticulating Splines